-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Depreciation history and growth rate from 2022 to Q1 2025.
- Mereo BioPharma Group plc Depreciation for the quarter ending March 31, 2025 was $38K, a 7.32% decline year-over-year.
- Mereo BioPharma Group plc Depreciation for the twelve months ending March 31, 2025 was $140K, a 17.6% decline year-over-year.
- Mereo BioPharma Group plc annual Depreciation for 2024 was $143K, a 16.4% decline from 2023.
- Mereo BioPharma Group plc annual Depreciation for 2023 was $171K, a 5.53% decline from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)